Experience of longterm treatment with anticoagulants in cerebrovascular accidents.
Explore the source record for details and available documents.
Anticoagulants↗
Biomedical subjects
C VERMYLEN
Publications and source records attributed to C VERMYLEN.
Antithrombin V: Critical evaluation of its assessment and properties.
Explore the source record for details and available documents.
Antithrombin Proteins↗
Disappearance of factor V activity after incubation of plasm with heparin and heparinoids.
Explore the source record for details and available documents.
Anticoagulants↗
Measurement of overall coagulabity during coumar in treatment with reference to the Quick test.
Explore the source record for details and available documents.
Blood Coagulation↗
[Experimental studies on some problems of blood coagulation with reference to extracorporeal circulation].
Explore the source record for details and available documents.
Blood Coagulation↗
[Chemical determination of coumarin derivatives].
Explore the source record for details and available documents.
Coumarins↗
Antithrombin activity: its interference with the estimation of antithrombin II activity in certain thrombin inhibitor determinations.
Explore the source record for details and available documents.
Anticoagulants↗
[Familial hemorhagic diathesis due to a qualitative deficiency of the blood platelets].
Explore the source record for details and available documents.
Blood Platelets↗
[Research on antithrombin V in Kahler's disease].
Explore the source record for details and available documents.
Antithrombin Proteins↗
[Research on antithrombin V in Kahler's disease].
Explore the source record for details and available documents.
Antithrombin Proteins↗
[Evaluation of anticoagulant therapy prolonged for 1302 months in 107 patients].
Explore the source record for details and available documents.
Anticoagulants↗
[Significance of the chemical determination of coumarin derivatives in clinical medicine].
Explore the source record for details and available documents.
Blood Coagulation↗
[DIFFERENTIATION OF THE INHIBITORS OF THE CONVERSION OF FIBRINOGEN INTO FIBRIN].
Explore the source record for details and available documents.
Antithrombin III↗